share_log

Bellerophon Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Puissance Life Science Opportunities Fund VI

Bellerophon Therapeutics | 4:持股變動聲明-股東 Puissance Life Science Opportunities Fund VI

SEC announcement ·  2023/06/07 21:21
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息